Combination HTNV and PUUV DNA Vaccine

Clinical trial NCT03718130 · COMPLETED

Trial details

NCT number: NCT03718130
Sponsor: U.S. Army Medical Research and Development Command
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hantaan Virus Disease, Puumala Virus

Start date: 2019-07-10
Primary completion: 2022-10-07
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.